Joseph Baroldi, EVP, Chief Business Officer at IONIS PHARMACEUTICALS INC (IONS), sold 30,000 shares at $68.01 ($2.0M) on 2025-10-02, disclosed to the SEC on 2025-10-02.
Scheduled sale ($2.0M) by EVP, Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.01 | 15,000 | $1.0M | 50.0% |
| 2 | $68.01 | 15,000 | $1.0M | 50.0% |
| Total | $68.01 avg | 30,000 | $2.0M | 100% |
| Filing → |
| IONS | SELL | 2026-04-17 | $419K | — | Filing → |
| IONS | SELL | 2026-03-05 | $531K | — | Filing → |
| IONS | SELL | 2026-02-02 | $439K | — | Filing → |